Find Funding Opportunities

The National Institute on Aging (NIA) and partnering NIH Institutes, Centers, and Offices (ICOs) intend to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to inviteapplications for a U54 Specialized Center (henceforth: Consortium) to provide resources, expertise, and coordination to advance innovative, high-quality research on palliative care for those with serious illness across the lifespan. This research infrastructure will encompass Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD), cancer, and other serious illnesses and populations relevant to the partnering Institutes, Centers, and Offices (ICOs). NIH currently funds many palliative care research projects across the ICOs, and there is a need for a structure to leverage synergies, coordinate efforts, develop the scientific workforce, and address remaining gaps in the field. The goals of this initiative include generating new scientific knowledge, in part through supporting pilot and exploratory studies; fostering development of early- and mid-career palliative care investigators; serving as a national platform to provide research resources and facilitate high-quality palliative care research; engaging healthcare systems and community-based organizations as research partners and settings for palliative care research; and disseminating research findings, best practices, data, and other impactful resources to the palliative care research and clinical communities. An important focus of the Consortiums work will be on facilitating research to understand and address disparities in access, quality, and use of palliative care services for health disparities populations or in underserved areas.

The National Institutes of Health (NIH) Environmental Justice Working Group invites feedback on the approaches NIH Institutes, Centers, and Offices can take to support research and capacity building efforts to advance environmental justice. Additionally, RFI responses will enable the NIH Environmental Justice Working Group to be responsive to Executive Order 14096 on Revitalizing Our Nations Commitment to Environmental Justice for All, and to synergize NIH efforts with other Federal Agencies in a whole of government approach to advance environmental justice.

This Funding Opportunity Announcement (FOA) invites applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released from industrial production, storage, or shipping. Projects supported by this FOA are expected to generate data that elucidate mechanisms of toxicity of these agents, possible new manifestations of toxic exposures, and potential new targets for therapeutic development.

The purpose of this notice is to inform applicants of a change to the allowable Appendix Materials for PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)".

The goal of this program is to provide support for a mentored research training experience for individuals with high potential to re-enter, re-integrate into, or re-train in an active research career, after an interruption for family responsibilities or other qualifying circumstances as described below. This program encourages re-entry, re-integration, and re-training administrative supplement applications to existing NIH research grants to support full or part-time mentored research experiences by these individuals. The supplement grants are intended to provide these scientists an opportunity to update or extend their research skills and knowledge and prepare them to re-establish or revitalize their careers in basic biomedical, behavioral, clinical, translational, or social science research. It is anticipated that by the completion of the supplement support period, the re-entry/re-integration/re-training supplement awardee will be prepared to apply for a fellowship (F), career development (K) award, a research award (R), SBIR/STTR, or other types of independent research support.

The purpose of this notice is to notify applicants of a correction to the Award Project Period for PAR-21-153 NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required).

The purpose of this notice is to notify applicants of a correction to the Award Project Period for PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)".

The purpose of this notice is to inform applicants of a correction to the Eligible Applicants for RFA-NS-24-024 "Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)". This NOFO has been revised to show that Non-domestic (non-U.S.) Entities (Foreign Institutions) are NOT eligible to apply.

TheNINDSOffice of Global Health and Health Disparities (OGHHD)will host a pre-application technical assistance webinar for those considering applying to the Community-Engaged Health Equity Research in Neuroscience (HERN) Initiative Funding Opportunities. NIH staff will discuss the funding opportunities and answer questions from prospective applicants. Participation in the webinar is encouraged but optional.

The purpose of this notice is to notify applicants of a correction to the table of page limits and Instructions for Submission of Multicomponent Applications for RFA-NS-24-011 "Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)".